UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~October~~March 2517, ~~2013~~2014

STALAR 1, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware	000-52971	26-1402640
(State or Other	(Commission	(IRS Employer
Jurisdiction of Incorporation)	File Number)	Identification Number)

317 Madison Ave., Suite 1520, New York, NY		10017
(Address of Principal Executive Offices)		(Zip Code)

(212) 953-1544 Registrant’s telephone number, including area code:

N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 45.01 Changes in ~~Registrant's~~Control ~~Certifying~~of ~~Accountant~~Registrant.

OnAs reported by Stalar 1, Inc. (the “Company”), on Form 8-K, filed on October 2517, 2013, pursuant to the ~~Company’s Board~~terms of a ~~Directors~~letter ~~approved~~agreement, Dr. Steven Fox, the ~~removal~~President, CEO, CFO and COO of ~~MNP~~the ~~LLP~~Company (“Dr. Fox”), and the ~~successor~~majority stockholder byof ~~merger~~the Company, agreed to ~~MSCM~~transfer certain of his shares of Common Stock of the Company, ~~LLP~~to Dr. Steven Rosenfeld (“Dr. Rosenfeld”), asor an entity 100% controlled by him, for nominal consideration and his agreement to reimburse Dr. Fox for certain operating expenses of the Company’s. ~~independent~~Subsequently, ~~registered~~Dr. Fox and Dr. Rosenfeld have amended the letter agreement, such amendment ~~public~~being ~~accountant~~dated March 17, 2014. Pursuant to the letter agreement, as amended, Dr. Fox agreed to transfer 1,022,250 shares, equating to a 50.00% ownership of the Company, to Dr. Rosenfeld. The aggregate consideration for the shares is: (i) the payment of $1,022.2; and ~~approved~~(ii), the ~~appointment~~reimbursement by Dr. Rosenfeld, to Dr. Fox, for 50% of ~~Merry~~the ~~Tang~~operating costs of ~~GTZY~~the ~~CPA~~Company, ~~Group~~and the agreement to continue to share in the operating costs of the Company, ~~LLC~~50/50 ~~(“GTZY”)~~with asDr. ~~MNP~~Fox, ~~LLP’s~~going ~~successor~~forward (collectively, the “Consideration”).

~~During~~On ~~the~~March ~~Company’s~~17, ~~previous~~2014, ~~fiscal~~in ~~years~~exchange ~~ended~~for ~~September~~the 30Consideration, ~~2008,~~and ~~September~~pursuant ~~30,~~to ~~2009,~~a ~~September~~Stock 30Power, ~~2010,~~Dr. ~~September~~Fox 30transferred 1,022,250 ~~2011~~shares ~~and~~of ~~September~~the ~~30,~~Company’s ~~2012~~Common Stock, ~~there were~~held noby ~~disagreements~~Dr. ~~between~~Fox, ~~the~~to ~~Company~~Park ~~and~~Avenue ~~MSCM,~~Discover ~~LLP~~#1 onLLC, ~~any~~a ~~matter~~Delaware oflimited ~~accounting~~liability ~~principles~~company. orFollowing ~~practices~~this transfer, ~~financial~~Dr. ~~statement~~Fox ~~disclosure,~~owns or46.60% ~~auditing~~of ~~scope~~the oroutstanding ~~procedure,~~Common ~~which~~Stock ~~disagreements~~of the Company, ifand ~~not~~Park ~~resolved~~Avenue toDiscover #1 LLC owns 50.00% of the ~~satisfaction~~outstanding Common Stock of ~~MSCM,~~the ~~LLP~~Company. Dr. Rosenfeld, ~~would~~as ~~have~~the ~~caused MSCM,~~100% ~~LLP~~owner toof ~~make~~Park ~~reference~~Avenue toDiscover #1 LLC is the ~~subject~~beneficial ~~matter~~owner of the ~~disagreements~~50.00% ownership in ~~connection~~the ~~with~~Company. ~~its~~The ~~audit~~source ~~reports~~of onfunds used to make payment of the ~~Company’s financial~~Consideration ~~statements~~was cash on hand, held by Dr. Rosenfeld.

~~The~~For ~~Company~~a ~~has~~description ~~not~~of ~~engaged MNP, LLP during~~ the Company’s ~~most recently completed fiscal year, ended September 30, 2013, and the subsequent interim period through~~ ~~October~~Common 25Stock, ~~2013,~~reference ~~the~~is ~~date~~hereby onmade ~~which~~to the Company’'s ~~Board~~registration ofstatement ~~Directors~~on ~~approved~~Form ~~the~~10-SB ~~engagement~~filed ofon ~~GTZY~~December ~~and MNP~~12, ~~LLP ceased being the Company’s auditors~~2007. During the Company’s past fiscal years ended September 30, 2012, and September 30, 2013 and the interim period through the approval of the engagement of GTZY, MNP, LLP did not advise the Company of any of the matters specified in Item 304(a)(1)(v) of Regulation S-K.

~~During~~Dr. ~~the~~Rosenfeld ~~period~~is ~~preceding~~an ~~the~~executive ~~engagement~~officer ofand ~~GTZY,~~director ~~the Company had no consultations with GTZY regarding (a) the application~~ of ~~accounting~~Stalar ~~principles~~5, toInc., a ~~specified~~Delaware ~~transaction~~corporation, ~~either~~ ~~completed~~which oris ~~proposed,~~an oraffiliate ~~the type~~ of ~~audit~~the ~~opinion~~Company ~~that~~by ~~might~~virtue beof ~~rendered~~Dr. ~~on the Company~~Fox’s ~~financial statements as~~ownership tointerest ~~which the Company received a written report or oral advice that was an important factor~~ in ~~reaching~~Stalar ~~a decision on any accounting~~5, ~~auditing~~ ~~or financial reporting issue; or (b) any disagreements, as defined in Item 304(a)(1)(iv) of Regulation S-K~~Inc.

~~The~~There ~~Company~~are ~~provided~~no ~~MNP,~~other ~~LLP~~arrangements ~~with a~~known ~~copy of this report on Form 8-K in accordance with Item 304(a) of Regulation S-K prior~~ to ~~its filing with~~ the ~~Securities and Exchange Commission and requested that MNP~~Company, ~~LLP~~including ~~furnish~~any ~~the~~pledge ~~Company~~by ~~with~~any aperson ~~letter~~of ~~addressed~~securities toof the ~~Securities~~Company, ~~and Exchange Commission stating whether it agrees with~~ the ~~above~~operation ~~statements~~of ~~and~~which may, ifat ita ~~does~~subsequent ~~not agree~~date, result ~~the respects~~ in ~~which~~a itfurther ~~does~~change ~~not~~in ~~agree.~~control ~~A copy~~ of the ~~letter from MNP, LLP is filed as Exhibit 16 hereto and incorporated herein by reference~~Company.

~~ITEM 9.01 FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.~~SIGNATURE

a)Pursuant ~~Not~~to ~~Applicable~~the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

b) Not Applicable.


	STALAR 1, INC.

Date: March 18, 2014	By:	/s/Steven R. Fox
		Steven R. Fox, President, Chief Executive Officer,
		Chief Operating Officer, and Chief Financial Officer (principal financial officer)

c)EXHIBIT ~~Exhibits~~INDEX

No. Exhibit

Exhibit No.	Description
99.1	First Amendment to Letter Agreement, dated March 17, 2014 between Dr. Fox and Dr. Rosenfeld.
99.2	Stock Power, dated March 17, 2014 executed by Dr. Fox.

16.1 Letter from MNP, LLP, Certified Public Accountants, dated October 30, 2013, regarding statements included in this Form 8-K.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	STALAR 1, INC.
Date: October 30, 2013	By:	/s/Steven R. Fox
		Chief Operating Officer and
		Chief Financial Officer (principal financial officer)

Filing Compare · Stalar 1, Inc.